What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...

Denali’s wholly owned program, DNL310 or tividenofusp alfa, is an Enzyme Transport Vehicle-enabled iduronate-2-sulfatase (IDS) replacement therapy in development for MPS II (Hunter syndrome).

This designation is in addition to Fast Track Designation, Orphan Drug Designation, and Rare Pediatric Disease Designation, all previously granted by the FDA for tividenofusp alfa in Hunter syndrome.

Hunter syndrome affects over 2,000 individuals, primarily males, in commercially accessible regions. With analysts maintaining a Strong Buy consensus and the company maintaining a healthy liquidity ...

Bulgaria and Romania rang in the new year with full entry to the European Union’s passport-free Schengen area, promising a fresh boost to their economies. The lifting of controls at land borders ...

Romania and Bulgaria have become full members of the European Union’s border-free Schengen area after scrapping land border controls in the bloc. The expansion was officially introduced at ...

Romania and Bulgaria have become full members of the Schengen zone, expanding the borderless area to 29 members and ending a 13-year wait for the two Eastern European countries. The expansion ...

Romania, Bulgaria drop EU border checks, join Schengen 01/01/2025 January 1, 2025 Two EU nations, Romania and Bulgaria, are eliminating land border controls to the rest of the bloc after Austria ...